Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  prednisolone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 103 for your search:
Start Over
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CABAZL06499, U1111-1131-3161, NCT02074137
Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: NILG-ALL 10/07, NCT00795756
Phase I/III Induction with ADR/ARA-C/VCR/PRDL and Consolidation and Maintenance with ADR/ARA-C, ADR/AZC, MePRDL/VCR/6-MP/MTX, or ARA-C for ANLL
Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: DFCI-76006, DFCI-VAPA-10
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 60
Sponsor: Other
Protocol IDs: EORTC-06951, FRE-LALA-94, NCT00002700
Phase III Randomized Study of Unrelated Donor BMT vs Continuing Chemotherapy for Childhood Acute Lymphoblastic Leukemia in First Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 6 months to under 21
Sponsor: NCI, Other
Protocol IDs: 5961, COG-C5961, CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, CDR0000064702, NCT00002757
Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728
Phase III Chemotherapy with POMP (6-MP/VCR/MTX/PRDL) vs 6-MP/MTX/PRED/CF/HC for Maintenance in Childhood Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 15
Sponsor: NCI
Protocol IDs: POG-7220/21
Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 365 days and under
Sponsor: Other
Protocol IDs: CDR0000068529, ICU-INTERFANT99, UKCCSG-LK-1999-05, EU-20063, EU-20588, NCT00015873
Phase III Combination Chemotherapy with Prednisolone, VCR, and L-ASP for Reinduction of Remission in Acute Lymphocytic Leukemia in Children
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: MDA-P-7730n
Start Over